Table 1 shows baseline median and interquartile ranges (IQR) values of age, BMI, serum adiponectin and leptin levels measured with the two methods by disease status (healthy at increased risk subjects from the Prevention IBIS-II Trial versus subjects with resected DCIS from the DCIS IBIS-II Trial). This evidence concerns the gene ADIPOQ and ductal breast carcinoma in situ.